At the practice of Dr
These factors may significantly influence GI AE incidence, as higher doses, oral administration, or rapid absorption may exacerbate nausea and vomiting, while gradual titration can mitigate such effects
and EU product information emphasise gastrointestinal adverse reactions (nausea, vomiting, diarrhoea, constipation, abdominal pain) as common with semaglutide, especially around dose escalation
Other trials identified that if a person already has some kidney damage then SGLT2 inhibitors may make it worse and this treatment is not recommended
When a peptide gets too hot, the amino acid chains unfold in a process called denaturation
For example, a Tier 3 or 4 medication might require a 30-50% coinsurance payment